58-week open-label trial of Tavapadon in Parkinson’s Disease (tempo-4 trial)

  • Iansek, Robert (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date19/05/21 → 18/05/26

Keywords

  • clinical trial
  • Parkinson's disease
  • treatment efficacy
  • treatment safety